AUROPHARMA.NSAUROPHARMA.NSNSE
Loading
Operating Income Growth Under PressureDecelerating
Percentile Rank64
5Y CAGR-10.3%
Year-over-Year Change
Year-over-year operating income growth rate
5Y CAGR
-10.3%/yr
Long-term compound
Percentile
P64
Within normal range
vs 5Y Ago
0.6x
Contraction
Streak
1 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2025 | 14.84% |
| 2024 | 28.94% |
| 2023 | 3.83% |
| 2022 | -16.99% |
| 2021 | 7.16% |
| 2020 | 25.57% |
| 2019 | 5.50% |
| 2018 | 8.84% |
| 2017 | 8.05% |
| 2016 | 18.66% |